Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5348080011 | Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5348081010 | Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | Is a | Product containing only piperacillin and tazobactam in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | Has manufactured dose form | Powder for conventional release solution for infusion and/or injection (dose form) | true | Inferred relationship | Some | ||
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Piperacillin sodium | true | Inferred relationship | Some | 1 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Piperacillin (substance) | true | Inferred relationship | Some | 1 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | This attribute specifies the numerator unit for the presentation strength of a product. | g | true | Inferred relationship | Some | 1 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | This attribute specifies the denominator unit for the presentation strength of a product. | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Tazobactam sodium (substance) | true | Inferred relationship | Some | 2 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Tazobactam | true | Inferred relationship | Some | 2 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | This attribute specifies the numerator unit for the presentation strength of a product. | mg | true | Inferred relationship | Some | 2 | |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | This attribute specifies the denominator unit for the presentation strength of a product. | Vial (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | True | Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | Inferred relationship | Some | |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Is a | True | Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial | Inferred relationship | Some |
This concept is not in any reference sets